These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 364356)
1. The effect of oral contraceptives on the gonadotropin response to LHRH. Rubinstein L; Moguilevsky J; Leiderman S Obstet Gynecol; 1978 Nov; 52(5):571-4. PubMed ID: 364356 [TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
3. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids. Scott JA; Brenner PF; Kletzky OA; Mishell DR Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817 [TBL] [Abstract][Full Text] [Related]
4. Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH+. Dericks-Tan JS; Krög W; Aktories K; Taubert HD Contraception; 1976 Aug; 14(2):171-81. PubMed ID: 780050 [No Abstract] [Full Text] [Related]
5. Effect of oral contraceptives on vitamin B6 nutriture of young women. Vir SC; Love AH Int J Vitam Nutr Res; 1980; 50(1):29-34. PubMed ID: 7390712 [TBL] [Abstract][Full Text] [Related]
6. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment]. Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402 [TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacology of hormonal contraceptives]. Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347 [No Abstract] [Full Text] [Related]
8. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state. de Kretser DM; Burger HG; Dumpys R J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423 [TBL] [Abstract][Full Text] [Related]
9. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women. Griffith SG; Dai Y Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769 [TBL] [Abstract][Full Text] [Related]
10. Pituitary LH response to LHRH during puerperium. Miyake A; Tanizawa O; Aono T; Kurachi K Obstet Gynecol; 1978 Jan; 51(1):37-40. PubMed ID: 339137 [TBL] [Abstract][Full Text] [Related]
11. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor. Vandenberg G; DeVane G; Yen SS J Clin Invest; 1974 Jun; 53(6):1750-4. PubMed ID: 4598115 [TBL] [Abstract][Full Text] [Related]
12. [Effects of synthetic sex steroids on the pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) (author's transl)]. Higashiyama S; Iwasaki T; Kizu S; Okada H Nihon Naibunpi Gakkai Zasshi; 1976 Jan; 52(1):72-82. PubMed ID: 767171 [TBL] [Abstract][Full Text] [Related]
13. Gonadotropin responses following luteinizing hormone releasing hormone administration in normal subjects. Wentz AC; Jones GS; Rocco L Obstet Gynecol; 1975 Mar; 45(3):239-46. PubMed ID: 1089927 [TBL] [Abstract][Full Text] [Related]
14. [The effect of different types of oral contraceptives upon ovarian function (author's transl)]. Aktories K; Krög W; Dericks-Tan JS; Jürgensen O; Taubert HD Geburtshilfe Frauenheilkd; 1976 Apr; 36(4):318-26. PubMed ID: 1269893 [TBL] [Abstract][Full Text] [Related]
15. Dissociation of LH and FSH Responses to LHRH during estrogen therapy of patients with ovarian failure. Linde R; Lindner J; Lorber D; Rabin D Horm Metab Res; 1982 Mar; 14(3):154-6. PubMed ID: 6802737 [TBL] [Abstract][Full Text] [Related]
16. [Testing of the steroid-related suppressive effect on the hypothalamo-hypophyseal system using twofold stimulation]. Carol W; Lauterbach H; Klinger G Zentralbl Gynakol; 1984; 106(6):359-67. PubMed ID: 6426199 [TBL] [Abstract][Full Text] [Related]
17. Hormonal content of plasma and endometrium of women taking oral contraceptives. Porias H; Carranco-López A; Sojo-Aranda I; González-Martínez R; Cervantes C; Parra A; Cortés-Gallegos V Obstet Gynecol; 1978 Dec; 52(6):703-7. PubMed ID: 733138 [TBL] [Abstract][Full Text] [Related]
18. Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles of oral contraceptives. Hansen AP; Weeke J Scand J Clin Lab Invest; 1974 Nov; 34(3):199-205. PubMed ID: 4428162 [TBL] [Abstract][Full Text] [Related]
19. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781 [TBL] [Abstract][Full Text] [Related]
20. Gonadotrophin hormone releasing tests in women receiving hormonal contraception. Perez-Lopez FR; L'Hermite M; Robyn C Clin Endocrinol (Oxf); 1975 Sep; 4(5):477-85. PubMed ID: 1100289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]